- Home
- VYGR vs ITRG Comparison
VYGR vs ITRG Comparison
Compare VYGR & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- ITRG
- Stock Information
- Founded
- VYGR 2013
- ITRG 1997
- Country
- VYGR United States
- ITRG Canada
- Employees
- VYGR N/A
- ITRG N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- ITRG Precious Metals
- Sector
- VYGR Health Care
- ITRG Basic Materials
- Exchange
- VYGR Nasdaq
- ITRG Nasdaq
- Market Cap
- VYGR 191.9M
- ITRG 227.8M
- IPO Year
- VYGR 2015
- ITRG N/A
- Fundamental
- Price
- VYGR $3.17
- ITRG $1.70
- Analyst Decision
- VYGR Strong Buy
- ITRG Strong Buy
- Analyst Count
- VYGR 9
- ITRG 1
- Target Price
- VYGR $14.86
- ITRG $2.75
- AVG Volume (30 Days)
- VYGR 282.0K
- ITRG 1.5M
- Earning Date
- VYGR 05-06-2025
- ITRG 05-14-2025
- Dividend Yield
- VYGR N/A
- ITRG N/A
- EPS Growth
- VYGR N/A
- ITRG N/A
- EPS
- VYGR N/A
- ITRG N/A
- Revenue
- VYGR $66,958,000.00
- ITRG $30,350,000.00
- Revenue This Year
- VYGR N/A
- ITRG $746.16
- Revenue Next Year
- VYGR $2.04
- ITRG N/A
- P/E Ratio
- VYGR N/A
- ITRG N/A
- Revenue Growth
- VYGR N/A
- ITRG N/A
- 52 Week Low
- VYGR $2.75
- ITRG $0.73
- 52 Week High
- VYGR $9.55
- ITRG $1.88
- Technical
- Relative Strength Index (RSI)
- VYGR 40.49
- ITRG 54.74
- Support Level
- VYGR $3.46
- ITRG $1.61
- Resistance Level
- VYGR $3.69
- ITRG $1.95
- Average True Range (ATR)
- VYGR 0.18
- ITRG 0.11
- MACD
- VYGR 0.00
- ITRG -0.02
- Stochastic Oscillator
- VYGR 0.00
- ITRG 26.87
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.